NCT03811665Unknown不适用
A Prospective Randomized Pilot Trial of Stereotactive Body Radiation Therapy Versus Radiofrequency Ablation for the Management of Small Renal Masses.
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Treatment failure
研究概览
简要总结
The execution of this study is pertinent to evaluating SBRT's short- and long-term efficacy and safety in the treatment of SRMs. This study will be the first to compare RFA and SBRT in the treatment of SRMs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥18 years of age and capable of providing informed consent
- •Patients scheduled for treatment of their SRM using SBRT or RFA
- •Patients who received a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
- •Patients who are willing to have a biopsy 12 months post-procedure
- •Patients with renal tumor(s) ≤ 4.0 cm
排除标准
- •Patients with large renal tumor(s)>4.0 cm
- •Patients who are unable to have a general anesthetic
- •Patients who did not receive a biopsy of their SRM prior to their scheduled SBRT or RFA treatment
- •Patients who are unable to comply with post-operative and/or follow-up protocol/phase of study
- •Evidence of metastatic disease
- •Uncorrectable bleeding diathesis
结局指标
主要结局
Treatment failure
时间窗: 12 Months
Failure will be defined as enhancement of ablated tissue greater than 10 Hounsfield units by CT contrast.
Overall Survival
时间窗: 12 Months
Defined as post-procedural survival.
Disease recurrence
时间窗: 12 Months
Defined as disease recurrence rate after a single procedure, including positive biopsy result.
Disease free survival
时间窗: 12 Months
Defined as disease-free survival rate after a single procedure
次要结局
- Tumour Size(12 Months)
- Renal Function -eGFR(12 Months)
- Renal Function - Creatinine Clearance(12 Months)
- Renal Function - Serum Creatinine(12 Months)
- Complication Rate(12 Months)
- Change in score for quality of life(12 Months)
- Duration of hospital stay(Days)
- Number of patients that experienced an adverse event.(12 Months)
- Cost analysis(12 Months)
研究者
Anil Kapoor
Principal Investigator
St. Joseph's Healthcare Hamilton
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare TumorsOligometastatic DiseaseNCT05903261Istituto Clinico Humanitas200
终止
不适用
A Trial on SBRT Versus MWA for Inoperable Colorectal Liver Metastases (CLM)Secondary Malignant Neoplasm of LiverNCT02820194Istituto Clinico Humanitas26
进行中（未招募）
不适用
A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the BoneMetastatic CancerNCT05038124Memorial Sloan Kettering Cancer Center39
招募中
2 期
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）Unresectable Locally Recurrent Rectal CancerNCT06767007Sixth Affiliated Hospital, Sun Yat-sen University31
招募中
不适用
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.Prostate CancerNCT06052683CHU de Quebec-Universite Laval208